Report generated from BNF provided by FormularyComplete ( Accessed TA Number. Title Formulary Status Section
|
|
- Merilyn Morgan
- 5 years ago
- Views:
Transcription
1 Report generated from BNF provided by FormularyComplete ( Accessed Title Formulary Status Section TA Number TA Link Annotation ABCIXIMAB 2.9 Antiplatelet drugs This drug is not used by this Trust as we use an alternative medicine positively appraised by NICE Actilyse Adalat Retard Adenocor ADENOSINE ADRENALINE/EPINEPHRINE Aldomet Aldosterone antagonists 2.10 Stable angina, acute coronary syndromes, and fibrinolysis-> Fibrinolytic drugs->alteplase blockers->nifedipine->modified release arrhythmias->supraventricular arrhythmias->adenosine arrhythmias->supraventricular arrhythmias 2.7 Sympathomimetics->2.7.3 Cardiopulmonary resuscitation 2.5 Hypertension and heart failure->2.5.2 Centrally acting antihypertensive drugs->methyldopa 2.2 Diuretics->2.2.3 Potassium-sparing diuretics and aldosterone antagonists Alpha-adrenoceptor blocking drugs 2.5 Hypertension and heart failure ALTEPLASE 2.10 Stable angina, acute coronary syndromes, and fibrinolysis-> Fibrinolytic drugs TA264 Amias affecting the renin-angiotensin system-> Angiotensin-II receptor antagonists->candesartan CILEXETIL First line Angiotensin 2 receptor antagonist for the treatment of Congestive Cardiac Failure. Amiloride 2.2 Diuretics->2.2.3 Potassium-sparing diuretics and aldosterone antagonists->amiloride HYDROCHLORIDE
2 AMILORIDE HYDROCHLORIDE 2.2 Diuretics->2.2.3 Potassium-sparing diuretics and aldosterone antagonists Amiodarone arrhythmias->supraventricular and ventricular arrhythmias->amiodarone HYDROCHLORIDE AMIODARONE HYDROCHLORIDE arrhythmias->supraventricular and ventricular arrhythmias AMLODIPINE blockers Amlodipine blockers->amlodipine Angiotensin-converting enzyme inhibitors affecting the renin-angiotensin system Angiotensin-II receptor antagonists affecting the renin-angiotensin system Angiox Parenteral anticoagulants->hirudins->bivalirudin This drug is not used by this Trust as we use an alternative medicine positively appraised by NICE. Anti-arrhythmic drugs Anticoagulants and protamine Antifibrinolytic drugs and haemostatics Antiplatelet drugs Apixaban anticoagulants NICE TA275 recommends apixaban as a possible treatment to prevent stroke and systemic embolism in some people with atrial fibrillation without underlying heart valve disease. APIXABAN anticoagulants->apixaban TA245 NICE TA275 recommends apixaban as a possible treatment to prevent stroke and systemic embolism in some people with atrial fibrillation without underlying heart valve disease. APIXABAN anticoagulants->apixaban TA341 NICE TA275 recommends apixaban as a possible treatment to prevent stroke and systemic embolism in some people with atrial fibrillation without underlying heart valve disease. APIXABAN anticoagulants->apixaban TA275 NICE TA275 recommends apixaban as a possible treatment to prevent stroke and systemic embolism in some people with atrial fibrillation without underlying heart valve disease.
3 Apresoline 2.5 Hypertension and heart failure->2.5.1 Vasodilator antihypertensive drugs->hydralazine HYDROCHLORIDE Aprovel affecting the renin-angiotensin system-> Angiotensin-II receptor antagonists->irbesartan Alternative to losartan in hypertension (particularly in hypertensive microalbuminuria/nephropathy). First line treatment for Microalbuminuria/Proteinuria (early and late nephropathy/diabetic and non-diabetic). Asasantin Retard 2.9 Antiplatelet drugs->dipyridamole->with aspirin Aspirin 2.9 Antiplatelet drugs->aspirin (antiplatelet) Aspirin EC tablets are non-formulary ASPIRIN (antiplatelet) 2.9 Antiplatelet drugs ATENOLOL drugs Atenolol BENDROFLUMETHIAZIDE Beta-adrenoceptor blocking drugs Beta-Cardone Betaloc drugs->atenolol 2.2 Diuretics->2.2.1 Thiazides and related diuretics drugs->sotalol HYDROCHLORIDE drugs->metoprolol TARTRATE BEZAFIBRATE drugs->fibrates Bezafibrate Bezalip drugs->fibrates->bezafibrate drugs->fibrates->bezafibrate Bile acid sequestrants drugs BISOPROLOL FUMARATE drugs For use in heart failure BIVALIRUDIN Parenteral anticoagulants->hirudins TA230 This drug is not used by this Trust as we use an alternative medicine positively appraised by NICE. Blood-related products 2.11 Antifibrinolytic drugs and haemostatics
4 Brilique 2.9 Antiplatelet drugs->ticagrelor Approved for use in ACS patients with a Tropinin Positive event undergoing an invasive strategy with a consultant cardiologist only as prescriber NICE TA236 Acute Coronary Syndromes - Recommended combined with low-dose aspirin for up to a year for treatment for specified people with ACS. BUMETANIDE 2.2 Diuretics->2.2.2 Loop diuretics Bumetanide 2.2 Diuretics->2.2.2 Loop diuretics->bumetanide Calcium-channel blockers other antianginal drugs CANDESARTAN CILEXETIL affecting the renin-angiotensin system-> Angiotensin-II receptor antagonists First line Angiotensin 2 receptor antagonist for the treatment of Congestive Cardiac Failure. Capoten affecting the renin-angiotensin system-> Angiotensin-converting enzyme inhibitors->captopril CAPTOPRIL affecting the renin-angiotensin system-> Angiotensin-converting enzyme inhibitors Captopril affecting the renin-angiotensin system-> Angiotensin-converting enzyme inhibitors->captopril Cardiac glycosides 2.1 Positive inotropic drugs Cardicor drugs->bisoprolol FUMARATE For use in heart failure Cardiopulmonary resuscitation 2.7 Sympathomimetics Cardura 2.5 Hypertension and heart failure->2.5.4 Alpha-adrenoceptor blocking drugs->doxazosin CARVEDILOL drugs For use in heart failure Carvedilol drugs->carvedilol For use in heart failure Centrally acting antihypertensive drugs 2.5 Hypertension and heart failure
5 CHLORTALIDONE 2.2 Diuretics->2.2.1 Thiazides and related diuretics To be used in accordance with NICE guidelines Clexane Parenteral anticoagulants->low molecular weight heparins->enoxaparin SODIUM CLOPIDOGREL 2.9 Antiplatelet drugs TA210 Avoid concomitant use of Omeprazole and esomeprazole. COLESTYRAMINE drugs->bile acid sequestrants Coracten XL blockers->nifedipine->modified release The D&T committee has agreed that Coracten XL should be used in place of Adalat LA Cozaar affecting the renin-angiotensin system-> Angiotensin-II receptor antagonists->losartan POTASSIUM First line Angiotensin 2 receptor antagonist for the treatment of hypertension (especially in LVH). Alternative to Irbesartan in Microalbuminuria /Proteinuria (established nephropathy in hypertensive diabetics +/- LVH). Cyklokapron 2.11 Antifibrinolytic drugs and haemostatics->tranexamic ACID Dabigatran etexilate anticoagulants Approved for Haematology use only to be used in Secondary Care for a target group of patients reacting to warfarin. NICE TA249 Atrial Fibrillation - a recommended option for AF patients with risk factors to prevent stroke and embolism DABIGATRAN ETEXILATE anticoagulants->dabigatran etexilate TA249 Approved for Haematology use only to be used in Secondary Care for a target group of patients reacting to warfarin. NICE TA249 Atrial Fibrillation - a recommended option for AF patients with risk factors to prevent stroke and embolism DABIGATRAN ETEXILATE anticoagulants->dabigatran etexilate TA157 Approved for Haematology use only to be used in Secondary Care for a target group of patients reacting to warfarin. NICE TA249 Atrial Fibrillation - a recommended option for AF patients with risk factors to prevent stroke and embolism DABIGATRAN ETEXILATE anticoagulants->dabigatran etexilate TA327 Approved for Haematology use only to be used in Secondary Care for a target group of patients reacting to warfarin. NICE TA249 Atrial Fibrillation - a recommended option for AF patients with risk factors to prevent stroke and embolism DANAPAROID SODIUM Parenteral anticoagulants->heparinoids Approved as an alternative anticoagulant in patients with Heparin-Induced Thrombocytopenia (HIT). DIGOXIN 2.1 Positive inotropic drugs->2.1.1 Cardiac glycosides Digoxin 2.1 Positive inotropic drugs->2.1.1 Cardiac glycosides->digoxin
6 Digoxin-specific antibody DILTIAZEM HYDROCHLORIDE 2.1 Positive inotropic drugs->2.1.1 Cardiac glycosides blockers DIPYRIDAMOLE 2.9 Antiplatelet drugs TA210 Dipyridamole 2.9 Antiplatelet drugs->dipyridamole DISOPYRAMIDE Disopyramide Diuretics arrhythmias->supraventricular and ventricular arrhythmias arrhythmias->supraventricular and ventricular arrhythmias->disopyramide Diuretics with potassium 2.2 Diuretics DOBUTAMINE 2.7 Sympathomimetics->2.7.1 Inotropic sympathomimetics Dopamine 2.7 Sympathomimetics->2.7.1 Inotropic sympathomimetics->dopamine HYDROCHLORIDE DOPAMINE HYDROCHLORIDE 2.7 Sympathomimetics->2.7.1 Inotropic sympathomimetics Doralese 2.5 Hypertension and heart failure->2.5.4 Alpha-adrenoceptor blocking drugs->indoramin DOXAZOSIN 2.5 Hypertension and heart failure->2.5.4 Alpha-adrenoceptor blocking drugs DRONEDARONE arrhythmias->supraventricular arrhythmias TA197 NICE TA197 Atrial Fibrillation - A recommended option for some people with non-permanent atrial fibrillation. Drugs affecting the renin-angiotensin system 2.5 Hypertension and heart failure Drugs for arrhythmias 2.3 Anti-arrhythmic drugs
7 Efient 2.9 Antiplatelet drugs->prasugrel NICE TA182 Acute Coronary Syndrome - A recommended option with aspirin for patients undergoing PCI in specific circumstances. Hertfordshire Medicines Mangement Committee (HMMC) Sept Green Status - Recommended for restricted use in specific subgoups in secondary and primary care for ACS (in combination with aspirin for the prevention of atherosclerotic events). Elantan LA other antianginal drugs->2.6.1 Nitrates->ISOSORBIDE MONONITRATE->Modified release Eliquis anticoagulants->apixaban->apixaban Included on Anticoagulant Prescription approved at APC 15/05/12 ENOXAPARIN SODIUM Parenteral anticoagulants->low molecular weight heparins EPHEDRINE HYDROCHLORIDE 2.7 Sympathomimetics->2.7.2 Vasoconstrictor sympathomimetics Ephedrine Hydrochloride 2.7 Sympathomimetics->2.7.2 Vasoconstrictor sympathomimetics->ephedrine HYDROCHLORIDE EPLERENONE 2.2 Diuretics->2.2.3 Potassium-sparing diuretics and aldosterone antagonists->aldosterone antagonists Consultant cardiologists initiation Epoprostenol Parenteral anticoagulants EPOPROSTENOL Parenteral anticoagulants->epoprostenol EPTIFIBATIDE 2.9 Antiplatelet drugs Ezetimibe drugs NICE TA132 Hypercholesterolaemia - A recommended option for heterozygous-familial and non-familial hypercholesterolaemia with a statin if cholesterol not low enough, or as monotherapy if a statin is unsuitable. EZETIMIBE drugs->ezetimibe TA132 NICE TA132 Hypercholesterolaemia - A recommended option for heterozygous-familial and non-familial hypercholesterolaemia with a statin if cholesterol not low enough, or as monotherapy if a statin is unsuitable.
8 Ezetrol drugs->ezetimibe->ezetimibe NICE TA132 Hypercholesterolaemia - A recommended option for heterozygous-familial and non-familial hypercholesterolaemia with a statin if cholesterol not low enough, or as monotherapy if a statin is unsuitable. Fibrates drugs Fibrinolytic drugs Flolan 2.10 Stable angina, acute coronary syndromes, and fibrinolysis Parenteral anticoagulants->epoprostenol->epoprostenol FUROSEMIDE 2.2 Diuretics->2.2.2 Loop diuretics Furosemide 2.2 Diuretics->2.2.2 Loop diuretics->furosemide GLYCERYL TRINITRATE other antianginal drugs->2.6.1 Nitrates Glyceryl Trinitrate other antianginal drugs->2.6.1 Nitrates->GLYCERYL TRINITRATE->Short-acting tablets and sprays Heparin Parenteral anticoagulants Heparin flushes Parenteral anticoagulants Heparinoids Parenteral anticoagulants Hirudins Parenteral anticoagulants Hydralazine 2.5 Hypertension and heart failure->2.5.1 Vasodilator antihypertensive drugs->hydralazine HYDROCHLORIDE HYDRALAZINE HYDROCHLORIDE 2.5 Hypertension and heart failure->2.5.1 Vasodilator antihypertensive drugs Hygroton 2.2 Diuretics->2.2.1 Thiazides and related diuretics->chlortalidone To be used in accordance with NICE guidelines Hypertension and heart failure
9 Ikorel INDORAMIN Innohep other antianginal drugs->2.6.3 Other antianginal drugs->nicorandil 2.5 Hypertension and heart failure->2.5.4 Alpha-adrenoceptor blocking drugs Parenteral anticoagulants->low molecular weight heparins->tinzaparin SODIUM Inotropic sympathomimetics 2.7 Sympathomimetics Inspra 2.2 Diuretics->2.2.3 Potassium-sparing diuretics and aldosterone antagonists->aldosterone antagonists->eplerenone Consultant Cardiologist initiation Integrilin 2.9 Antiplatelet drugs->eptifibatide IRBESARTAN affecting the renin-angiotensin system-> Angiotensin-II receptor antagonists Alternative to losartan in hypertension (particularly in hypertensive microalbuminuria/nephropathy). First line treatment for Microalbuminuria/Proteinuria (early and late nephropathy/diabetic and non-diabetic). ISOSORBIDE MONONITRATE other antianginal drugs->2.6.1 Nitrates Isosorbide Mononitrate other antianginal drugs->2.6.1 Nitrates->ISOSORBIDE MONONITRATE Istin blockers->amlodipine IVABRADINE other antianginal drugs->2.6.3 Other antianginal drugs TA267 ' LABETALOL HYDROCHLORIDE drugs Lanoxin-PG Lanoxin Lasix 2.1 Positive inotropic drugs->2.1.1 Cardiac glycosides->digoxin 2.1 Positive inotropic drugs->2.1.1 Cardiac glycosides->digoxin 2.2 Diuretics->2.2.2 Loop diuretics->furosemide
10 Lidocaine arrhythmias->ventricular arrhythmias->lidocaine HYDROCHLORIDE LIDOCAINE HYDROCHLORIDE arrhythmias->ventricular arrhythmias Lipid-regulating drugs Lipostat drugs->statins->pravastatin SODIUM The D&T committee (13/03/06) agreed that patients on simvastatin prone to chest infections, in the view of the Respiratory Physician, and in need of macrolide antibiotics, should have their simvastatin changed to pravastatin. LISINOPRIL affecting the renin-angiotensin system-> Angiotensin-converting enzyme inhibitors Local sclerosants Longer-acting formulations blockers->diltiazem HYDROCHLORIDE Loniten 2.5 Hypertension and heart failure->2.5.1 Vasodilator antihypertensive drugs->minoxidil Loop diuretics 2.2 Diuretics Lopresor drugs->metoprolol TARTRATE LOSARTAN POTASSIUM affecting the renin-angiotensin system-> Angiotensin-II receptor antagonists First line Angiotensin 2 receptor antagonist for the treatment of hypertension (especially in LVH). Alternative to Irbesartan in Microalbuminuria /Proteinuria (established nephropathy in hypertensive diabetics +/- LVH). Low molecular weight heparins Parenteral anticoagulants MANNITOL 2.2 Diuretics->2.2.5 Osmotic diuretics Mannitol Metalyse METARAMINOL 2.2 Diuretics->2.2.5 Osmotic diuretics->mannitol 2.10 Stable angina, acute coronary syndromes, and fibrinolysis-> Fibrinolytic drugs->tenecteplase 2.7 Sympathomimetics->2.7.2 Vasoconstrictor sympathomimetics
11 Metaraminol METHYLDOPA Methyldopa METOLAZONE 2.7 Sympathomimetics->2.7.2 Vasoconstrictor sympathomimetics->metaraminol 2.5 Hypertension and heart failure->2.5.2 Centrally acting antihypertensive drugs 2.5 Hypertension and heart failure->2.5.2 Centrally acting antihypertensive drugs->methyldopa 2.2 Diuretics->2.2.1 Thiazides and related diuretics METOPROLOL TARTRATE drugs Metoprolol Tartrate drugs->metoprolol TARTRATE Minijet Lignocaine arrhythmias->ventricular arrhythmias->lidocaine HYDROCHLORIDE MINOXIDIL 2.5 Hypertension and heart failure->2.5.1 Vasodilator antihypertensive drugs Modified release drugs->propranolol HYDROCHLORIDE Modified release other antianginal drugs->2.6.1 Nitrates->ISOSORBIDE MONONITRATE Modified release blockers->nifedipine Unlicensed use of nifedipine as a tocolyic agent currently under review. Unlicensed use needs to be aknowledged by the Trust Board. Modified release blockers->verapamil HYDROCHLORIDE Modified release 2.9 Antiplatelet drugs->dipyridamole Modified release drugs->fibrates->bezafibrate Multaq arrhythmias->supraventricular arrhythmias->dronedarone NICE TA197 Atrial Fibrillation - A recommended option for some people with non-permanent atrial fibrillation.
12 Naftidrofuryl other antianginal drugs->2.6.4 Peripheral vasodilators and related drugs->naftidrofuryl OXALATE NAFTIDROFURYL OXALATE other antianginal drugs->2.6.4 Peripheral vasodilators and related drugs TA223 NICORANDIL other antianginal drugs->2.6.3 Other antianginal drugs Nicorandil other antianginal drugs->2.6.3 Other antianginal drugs->nicorandil NIFEDIPINE blockers The unlicensed use of Nifedipine as a tocolytic agent is currently under review. (D&T Minutes 14/07/03) NIMODIPINE blockers Nimotop blockers->nimodipine Nitrates other antianginal drugs Nitrates, calcium-channel blockers, and other antianginal drugs Nitrocine other antianginal drugs->2.6.1 Nitrates->GLYCERYL TRINITRATE->Parenteral preparations NORADRENALINE/NOREPINEPHRINE 2.7 Sympathomimetics->2.7.2 Vasoconstrictor sympathomimetics Oral anticoagulants 2.8 Anticoagulants and protamine
13 Orgaran Parenteral anticoagulants->heparinoids->danaparoid SODIUM Approved as an alternative anticoagulant in patients with Heparin-Induced Thrombocytopenia (HIT). Osmotic diuretics 2.2 Diuretics Other antianginal drugs other antianginal drugs Parenteral anticoagulants 2.8 Anticoagulants and protamine Parenteral preparations Peripheral vasodilators and related drugs other antianginal drugs->2.6.1 Nitrates->GLYCERYL TRINITRATE other antianginal drugs Persantin 2.9 Antiplatelet drugs->dipyridamole Persantin Retard 2.9 Antiplatelet drugs->dipyridamole->modified release Phaeochromocytoma 2.5 Hypertension and heart failure->2.5.4 Alpha-adrenoceptor blocking drugs PHENTOLAMINE MESILATE 2.5 Hypertension and heart failure->2.5.4 Alpha-adrenoceptor blocking drugs->phaeochromocytoma Phenylephrine 2.7 Sympathomimetics->2.7.2 Vasoconstrictor sympathomimetics->phenylephrine HYDROCHLORIDE Used for treating hypotension during caesarean section. Ephedrine injection used for treating hypotension with bradycardia during caesarean section. PHENYLEPHRINE HYDROCHLORIDE 2.7 Sympathomimetics->2.7.2 Vasoconstrictor sympathomimetics Used for treating hypotension during caesarean section. Ephedrine injection used for treating hypotension with bradycardia during caesarean section. Plavix 2.9 Antiplatelet drugs->clopidogrel Positive inotropic drugs Potassium-sparing diuretics and aldosterone antagonists Potassium-sparing diuretics with other diuretics 2.2 Diuretics 2.2 Diuretics
14 Pradaxa anticoagulants->dabigatran etexilate->dabigatran ETEXILATE PRASUGREL 2.9 Antiplatelet drugs TA317 NICE TA182 Acute Coronary Syndrome - A recommended option with aspirin for patients undergoing PCI in specific circumstances. Hertfordshire Medicines Mangement Committee (HMMC) Sept Green Status - Recommended for restricted use in specific subgoups in secondary and primary care for ACS (in combination with aspirin for the prevention of atherosclerotic events). Pravastatin drugs->statins->pravastatin SODIUM The D&T committee (13/03/06) agreed that patients on simvastatin prone to chest infections, in the view of the Respiratory Physician, and in need of macrolide antibiotics, should have their simvastatin changed to pravastatin. PRAVASTATIN SODIUM drugs->statins The D&T committee (13/03/06) agreed that patients on simvastatin prone to chest infections, in the view of the Respiratory Physician, and in need of macrolide antibiotics, should have their simvastatin changed to pravastatin. Praxilene other antianginal drugs->2.6.4 Peripheral vasodilators and related drugs->naftidrofuryl OXALATE Procoralan other antianginal drugs->2.6.3 Other antianginal drugs->ivabradine ' Propranolol drugs->propranolol HYDROCHLORIDE PROPRANOLOL HYDROCHLORIDE drugs Protamine sulfate 2.8 Anticoagulants and protamine RAMIPRIL affecting the renin-angiotensin system-> Angiotensin-converting enzyme inhibitors Ramipril affecting the renin-angiotensin system-> Angiotensin-converting enzyme inhibitors->ramipril Ranexa other antianginal drugs->2.6.3 Other antianginal drugs->ranolazine Consultant initiation only. Hospital only initiation.. Review by consultant in 4-6 weeks for further treatment and/or dose titration. Refer to GP only if patient stable and not requiring dose titration
15 Rapilysin 2.10 Stable angina, acute coronary syndromes, and fibrinolysis-> Fibrinolytic drugs->reteplase This drug is not used by the Trust as we use an alternative medicine positively appraised by NICE. ReoPro 2.9 Antiplatelet drugs->abciximab This drug is not used by this Trust as we use an alternative medicine positively appraised by NICE RETEPLASE 2.10 Stable angina, acute coronary syndromes, and fibrinolysis-> Fibrinolytic drugs This drug is not used by the Trust as we use an alternative medicine positively appraised by NICE. Rivaroxaban anticoagulants RIVAROXABAN anticoagulants->rivaroxaban TA256 RIVAROXABAN anticoagulants->rivaroxaban TA170 RIVAROXABAN anticoagulants->rivaroxaban TA261 RIVAROXABAN anticoagulants->rivaroxaban TA287 RIVAROXABAN anticoagulants->rivaroxaban TA335 Rythmodan arrhythmias->supraventricular and ventricular arrhythmias->disopyramide Short-acting tablets and sprays other antianginal drugs->2.6.1 Nitrates->GLYCERYL TRINITRATE SIMVASTATIN drugs->statins First line statin Simvastatin drugs->statins->simvastatin First line statin SODIUM NITROPRUSSIDE 2.5 Hypertension and heart failure->2.5.1 Vasodilator antihypertensive drugs Sodium Nitroprusside 2.5 Hypertension and heart failure->2.5.1 Vasodilator antihypertensive drugs->sodium NITROPRUSSIDE SODIUM TETRADECYL SULFATE 2.13 Local sclerosants
16 Sotacor Sotalol drugs->sotalol HYDROCHLORIDE drugs->sotalol HYDROCHLORIDE SOTALOL HYDROCHLORIDE drugs Stable angina, acute coronary syndromes, and fibrinolysis Standard formulations blockers->diltiazem HYDROCHLORIDE Statins drugs Streptase 2.10 Stable angina, acute coronary syndromes, and fibrinolysis-> Fibrinolytic drugs->streptokinase This drug is not used by the Trust as we use an alternative medicine positively appraised by NICE STREPTOKINASE 2.10 Stable angina, acute coronary syndromes, and fibrinolysis-> Fibrinolytic drugs This drug is not used by the Trust as we use an alternative medicine positively appraised by NICE Supraventricular and ventricular arrhythmias arrhythmias Supraventricular arrhythmias arrhythmias Sympathomimetics TENECTEPLASE 2.10 Stable angina, acute coronary syndromes, and fibrinolysis-> Fibrinolytic drugs Tenormin drugs->atenolol Thiazides and related diuretics 2.2 Diuretics TICAGRELOR 2.9 Antiplatelet drugs TA236 Approved for use in ACS patients with a Tropinin Positive event undergoing an invasive strategy with a consultant cardiologist only as prescriber. NICE TA236 Acute Coronary Syndromes - Recommended combined with low-dose aspirin for up to a year for treatment for specified people with ACS. Tildiem LA blockers->diltiazem HYDROCHLORIDE->Longer-acting formulations
17 Tildiem Retard TINZAPARIN SODIUM blockers->diltiazem HYDROCHLORIDE->Longer-acting formulations Parenteral anticoagulants->low molecular weight heparins TIROFIBAN 2.9 Antiplatelet drugs This drug is not used by the Trust as we use an alternative medicine positively appraised by NICE. TRANEXAMIC ACID 2.11 Antifibrinolytic drugs and haemostatics Transdermal preparations Transiderm-Nitro Tritace other antianginal drugs->2.6.1 Nitrates->GLYCERYL TRINITRATE other antianginal drugs->2.6.1 Nitrates->GLYCERYL TRINITRATE->Transdermal preparations affecting the renin-angiotensin system-> Angiotensin-converting enzyme inhibitors->ramipril Vasoconstrictor sympathomimetics 2.7 Sympathomimetics Vasodilator antihypertensive drugs 2.5 Hypertension and heart failure Ventricular arrhythmias Verapamil VERAPAMIL HYDROCHLORIDE Warfarin WARFARIN SODIUM arrhythmias blockers->verapamil HYDROCHLORIDE blockers anticoagulants->coumarins and phenindione->warfarin SODIUM anticoagulants->coumarins and phenindione
18 With aspirin 2.9 Antiplatelet drugs->dipyridamole Xarelto anticoagulants->rivaroxaban->rivaroxaban Zestril affecting the renin-angiotensin system-> Angiotensin-converting enzyme inhibitors->lisinopril Zocor drugs->statins->simvastatin First line statin Aldactone 2.2 Diuretics->2.2.3 Potassium-sparing diuretics and aldosterone antagonists->aldosterone antagonists->spironolactone use - see BNF indications ALISKIREN affecting the renin-angiotensin system-> Renin inhibitors To be prescribed by a consultant cardiologist only and used as a 4th line treatment in patients whose blood pressure was still above target and taking an ACEI/ARB, Calcium Channel Blocker and a diuretic (ACD NICE Guidelines in Hypertension 2006). Patients should be actively followed up ATORVASTATIN drugs->statins Second choice - Alternative to simvastatin or pravastatin. In appropriate circumstances, atorvastatin doses of 10 and 20 mg daily to be changed to Simvastatin 40 mg daily (See separate Statin switch Guidelines). Crestor drugs->statins->rosuvastatin Prescribed by consultant cardiologist only FACTOR VIIa (RECOMBINANT) 2.11 Antifibrinolytic drugs and haemostatics->blood-related products Consultant haematologist use only. Funding should be agreed. Flecainide arrhythmias->supraventricular and ventricular arrhythmias->flecainide ACETATE Flecainide available on a prescription signed by a consultant cardiologist only. FLECAINIDE ACETATE arrhythmias->supraventricular and ventricular arrhythmias Flecainide available on a prescription signed by a consultant cardiologist only. Lipitor drugs->statins->atorvastatin Second choice - Alternative to simvastatin or pravastatin. In appropriate circumstances, atorvastatin doses of 10 and 20 mg daily to be changed to Simvastatin 40 mg daily (See separate Statin switch Guidelines). Micardis affecting the renin-angiotensin system-> Angiotensin-II receptor antagonists->telmisartan Approved as first line ARB in treating hypertension in the elderly.
19 Pletal other antianginal drugs->2.6.4 Peripheral vasodilators and related drugs->cilostazol Available on a consultant signature only. Patients are to be reviewed in clinic after four months. RANOLAZINE other antianginal drugs->2.6.3 Other antianginal drugs Consultant initiation only. Review by consultant in 4-6 weeks for further treatment and/or dose titration. Refer to GP only if patient stable and not requiring dose titration Rasilez affecting the renin-angiotensin system-> Renin inhibitors->aliskiren Renin inhibitors affecting the renin-angiotensin system To be prescribed by a consultant cardiologist only and used as a 4th line treatment in patients whose blood pressure was still above target and taking an ACEI/ARB, Calcium Channel Blocker and a diuretic (ACD NICE Guidelines in Hypertension 2006). Patients should be actively followed up ROSUVASTATIN drugs->statins Prescribed by consultant cardiologist only SPIRONOLACTONE 2.2 Diuretics->2.2.3 Potassium-sparing diuretics and aldosterone antagonists->aldosterone antagonists use - See BNF indications Spironolactone 2.2 Diuretics->2.2.3 Potassium-sparing diuretics and aldosterone antagonists->aldosterone antagonists->spironolactone Use - See BNF indications Tambocor arrhythmias->supraventricular and ventricular arrhythmias->flecainide ACETATE Flecainide available on a prescription signed by a consultant cardiologist only. TELMISARTAN affecting the renin-angiotensin system-> Angiotensin-II receptor antagonists Approved as first line ARB in treating hypertension in the elderly.
Chapter / Section / Drug
2 Cardiovascular System 2.1 Positive inotropic drugs Digoxin Digoxin specific antibody ( DigiFab ) 2.2 Diuretics 2.2.1 Thiazides and related diuretics Indapamide (1 st Line) Bendroflumethiazide Metolazone
More informationChapter 2 ~ Cardiovascular system
Chapter 2 ~ Cardiovascular System: General Section 1 of 6 Chapter 2 ~ Cardiovascular system 2.1 Positive inotropic drugs 2.1.1 Cardiac glycosides DIGOXIN 2.2 Diuretics Elixir 50micrograms in 1ml Injection
More information5mg/5mL Liquid 25mg Tablets 50mg Tablets 100mg Tablets 50mg/5mL Suspension Special standardise strength 25mg Tablets
Chapter 2- Cardiovascular Category Drug name Strength / dose / form BCU 2.1 Positive Inotropic drugs 2.1.1 Cardiac Digoxin 62.5 microgram Tablets Glycosides 125 microgram Tablets 250 microgram Tablets
More informationChapter 2 - Cardiovascular System. Primary Care Prescribing Formulary - Preferred Drug Choices
Chapter 2 - Cardiovascular System Primary Care Prescribing Formulary - Preferred Drug Choices Drug group Drug choice Comments/notes Cardiac glycosides Thiazide diuretics Loop diuretics Aldosterone antagonist
More information2. Cardiovascular System
1 2. Cardiovascular System 2.1 - Positive inotropic drugs 2.1.1 Cardiac glycosides Digoxin H - Digoxin specific antibody (Digifab ) Digoxin is indicated for rate control in atrial fibrillation and as add-on
More information2. Cardiovascular System
1 2. Cardiovascular System 2.1 - Positive inotropic drugs 2.1.1 Cardiac glycosides Digoxin H - Digoxin specific antibody (Digifab ) Digoxin is indicated for rate control in atrial fibrillation and as add-on
More informationCardiac Medications At A Glance
Cardiac Medications At A Glance 1) Anticoagulants (Also known as Blood Thinners.) Dalteparin (Fragmin), Danaparoid (Orgaran) Enoxaparin (Lovenox) Heparin (various) Tinzaparin (Innohep) Warfarin (Coumadin)
More informationBeta-blockers. Atenolol. Propranolol. Bisoprolol. Metoprolol. Labetalol. Carvedilol.
Drugs of CVS Beta-blockers Atenolol. Propranolol. Bisoprolol. Metoprolol. Labetalol. Carvedilol. Atenolol.cardioselective Propranolol, nonselective Bisoprolol, cardioselective Metoprolol Carvedilol, alpha
More informationCardiovascular Risk Reduction in Diabetic Mellitus. Presenter: Dr. Martin N. Wanyoike MB.CHB., M. Med.(internal med) Physician / Cardiologist
Cardiovascular Risk Reduction in Diabetic Mellitus Presenter: Dr. Martin N. Wanyoike MB.CHB., M. Med.(internal med) Physician / Cardiologist Cardiovascular Risk Reduction in Diabetic Mellitus Disclosures
More informationBack. Thiazide diuretics Drug Indication Formulation Notes on prescribing Bendroflumethiazide Hypertension, oedema Tablets
Cardiovascular System General information Diuretics and related drugs Anti-arrhythmic drugs Drugs affecting the renin - angiotensin system Calcium channel blockers α-adrenoreceptor blocking drugs β-adrenoreceptor
More informationACEBUTOLOL HCL 100MG TABLET GENERIC BETA BLOCKERS ALISKIREN 150MG TABLET RASILAZ RENIN INHIBITOR
S/N ME OF MEDICATIONS BRANDED/GENERIC DRUG CLASS * UNIT PRICE RANGE (SGD$) 1 ACEBUTOLOL HCL 100MG CAPSULE SECTRAL BETA BLOCKERS 0.50 2 ACEBUTOLOL HCL 100MG TABLET GENERIC BETA BLOCKERS 0.33 3 ALISKIREN
More informationSandwell and West Birmingham Hospitals NHS Trust
Sandwell and West Birmingham Hospitals NHS Trust Sandwell and West Birmingham Clinical Commissioning Group The drugs contained in the formulary of Sandwell and West Birmingham Hospitals Trust are listed
More informationCARDIAC REHABILITATION PROGRAMME:- MEDICATION
CARDIAC REHABILITATION PROGRAMME:- MEDICATION AIM OF THIS SESSION Understand the reasons for taking your medications, Discuss the common side effects associated with these medications - knowing when to
More informationChapter 2 Cardiovascular System
Chapter 2 page number 1 Chapter 2 Cardiovascular System First line drugs Drugs recommended in both primary and secondary care Second line drugs Alternatives (often in specific conditions) in both primary
More information2.1.2 CARDIAC GLYCOSIDES
2.1.2 CARDIAC GLYCOSIDES Digoxin 62.5, 125, 250microgram tablets 50 micrograms/ml elixir 100 micrograms/ml injection (paed) (special) 500 micrograms/2ml injection The dose of digoxin has to be tailored
More informationManagement of Hypertension
Clinical Practice Guidelines Management of Hypertension Definition and classification of blood pressure levels (mmhg) Category Systolic Diastolic Normal
More informationCardiovascular system
Contents: Cardiovascular system 1. Hypertension 2 2. Hypertensive crises 4 3. Heart failure acute 5 4. Heart failure (chronic management) 6 5. Acute chest pain, angina and acute coronary syndromes (including
More informationCardiovascular system
Cardiovascular system A. Positive inotropic drugs Drug classifications: Cardiac glycosides - Digoxin, Digitoxin Phosphodiesterase inhibitors - Enoximone, milrinone Inotropic sympathomimetics - dobutamine,
More informationAtrial Fibrillation Version 2 11/4/15 This order set must be used with an admission order set if patient not already admitted.
Patient Name: Diagnosis: Allergies with reaction type: Atrial Fibrillation Version 2 11/4/15 This order set must be used with an admission order set if patient not already admitted. Telemetry Medical Telemetry:
More informationMedications. Your prescriptions can be filled by your home pharmacy or by the Michigan Medicine Taubman Center outpatient pharmacy.
Medications Your prescriptions can be filled by your home pharmacy or by the Michigan Medicine Taubman Center outpatient pharmacy. What do I need to know about medications after my heart attack? When you
More informationAntihypertensive Agents Part-2. Assistant Prof. Dr. Najlaa Saadi PhD Pharmacology Faculty of Pharmacy University of Philadelphia
Antihypertensive Agents Part-2 Assistant Prof. Dr. Najlaa Saadi PhD Pharmacology Faculty of Pharmacy University of Philadelphia Agents that block production or action of angiotensin Angiotensin-converting
More informationInformation in these slides is used with permission from St. Mary s Cardiac Rehab
Information in these slides is used with permission from St. Mary s Cardiac Rehab Prescription Pointers Heart Medications Questions!! 2-4% of patients who visit ER s have experienced a medication misadventure
More informationHypertension (JNC-8)
Hypertension (JNC-8) Southern California University of Health Sciences Physician Assistant Program Management and Treatment of Hypertension April 17, 2018, presented by Ezra Levy, Pharm.D.! The 8 th Joint
More informationContents: 1. Hypertension
Contents: Cardiovascular system Medicines Formulary 1. Hypertension 2 2. Hypertensive crises 4 3. Heart failure acute 5 4. Heart failure (chronic management) 6 5. Acute chest pain, angina and acute coronary
More informationCardiovascular drugs
chapter 13 Cardiovascular drugs Cardiovascular drugs act on the heart or blood vessels to control the cardiovascular system. They are used to treat a variety of conditions from hypertension to chronic
More informationAntihypertensive drugs SUMMARY Made by: Lama Shatat
Antihypertensive drugs SUMMARY Made by: Lama Shatat Diuretic Thiazide diuretics The loop diuretics Potassium-sparing Diuretics *Hydrochlorothiazide *Chlorthalidone *Furosemide *Torsemide *Bumetanide Aldosterone
More informationMedications and your Heart. RBCH Foundation Trust
Medications and your Heart RBCH Foundation Trust Today I will try and cover Confusing cocktail of drugs? What are they for? How do I take them? What if I forget to take them? What are common side effects?
More informationSelect Preventive Prescription Drugs Jan. 1, 2018
Select Preventive Prescription Drugs Jan. 1, 2018 In addition to a healthy lifestyle, preventive medications can help you avoid some illnesses and conditions. Zimmer Biomet's medical options Value HSA,
More informationperioperative management of cardiovascular drugs
perioperative management of cardiovascular drugs Dave Pappin and Vanessa Helliwell, Exeter, UK. Email: vanessahelliwell@doctors.org.uk It is estimated that by 2010 cardiovascular disease will be the leading
More informationASEBP and ARTA TARP Drugs and Reference Price by Categories
ASEBP Pantoprazole Sodium 40 mg (generic) $0.2016 ASEBP Dexlansoprazole 30 mg Dexlansoprazole 60 mg Esomeprazole 10 mg Esomeprazole 20 mg Esomeprazole 40 mg Lansoprazole 15 mg Lansoprazole 30 mg Omeprazole
More informationEvaluation and Management of Acute Decompensated Heart Failure (HF) with Reduced Ejection Fraction Systolic Heart Failure (HFrEF)(EF<40%
Evaluation and Management of Acute Decompensated Heart Failure (HF) with Reduced Ejection Fraction Systolic Heart Failure (HFrEF)(EF
More informationPassAssured's Pharmacy Technician Training Systems. Medication Review. Cardiovascular Drugs. Pharmacy Technician Training Systems Passassured, LLC
Medication Review Cardiovascular Drugs Pharmacy Technician Training Systems Passassured, LLC p1 Medication Review, Cardiovascular Drugs Click Here for Glossary Index! Click Here to Print Topic Help File
More informationComprehensive Drug Information for Smith, John
PATIENT INFORMATION Name: Smith, John DOB: April 22, 1973 Age: 42 Sex: Male SAMPLE Date Collected: March 21, 2016 Date Received: March 21, 2016 Case ID: CARDI16-000001 Source: Buccal Swabs Comprehensive
More informationAntihypertensive drugs: I. Thiazide and other diuretics:
Clinical assessment of hypertensive patient: You have to take history regarding the presence of other risk factors for CAb like diabetes mellitus, smoking, etc. Take history whether the patient takes medications
More information12.5mg, 25mg, 50mg. 25mg, 50mg. 2.5mg, 5mg, 10mg. 5mg, 10mg, 20mg, 100mg. 25mg. -- $2.81 Acetazolamide (IR, 125mg, 250mg, 500mg (ER)
MEDICATION COVERAGE POLICY PHARMACY AND THERAPEUTICS ADVISORY COMMITTEE POLICY: Blood Pressure P&T DATE: 5/9/2017 THERAPEUTIC CLASS: Cardiovascular Disorders REVIEW HISTORY: 9/15, 2/13, 2/08, 5/07 LOB
More informationTREATMENT OF HYPERTENSION
TREATMENT OF HYPERTENSION Aim of treatment BP Goals Main items of treatment Lifestyle modification When to start drug Rx Pharmacological therapy 1. Relief of symptoms 2. Prevention of complications and
More information2 CARDIOVASCULAR SYSTEM
2 CARDIOVASCULAR SYSTEM 2.01 THIAZIDE, OSMOTIC & LOOP DIURETICS - THIAZIDES [TD], POTASSIUM SPARING [PSD], LOOP DIURETICS [LD] Frusemide Inj 10mg/ml, 2ml (Lasix) [Furosemide] [LD] Frusemide Tab 40mg (Lasix)
More informationIntroductory Clinical Pharmacology Chapter 41 Antihypertensive Drugs
Introductory Clinical Pharmacology Chapter 41 Antihypertensive Drugs Blood Pressure Normal = sys
More informationAntihypertensive Agents
Antihypertensive Agents Southern California University of Health Sciences Physician Assistant Program Management and Treatment of Hypertension April 7, 08, presented by Ezra Levy, Pharm.D! Usual Dose,
More informationChapter 20. Drugs Affecting Circulation: Antihypertensives, Antianginals, Antithrombotics
Chapter 20 Drugs Affecting Circulation: Antihypertensives, Antianginals, Antithrombotics Epidemiology and Etiology of Hypertension Primary: Unknown etiology Secondary: Due to known disease process Adversely
More informationHeart Failure Clinician Guide JANUARY 2016
Kaiser Permanente National CLINICAL PRACTICE GUIDELINES Heart Failure Clinician Guide JANUARY 2016 Introduction This evidence-based guideline summary is based on the 2016 National Heart Failure Guideline.
More informationHeart Failure Clinician Guide JANUARY 2018
Kaiser Permanente National CLINICAL PRACTICE GUIDELINES Heart Failure Clinician Guide JANUARY 2018 Introduction This evidence-based guideline summary is based on the 2018 National Heart Failure Guideline.
More informationMedicines for Heart Disease
Medicines for Heart Disease There are many medicines to treat heart disease. Ask your doctor, nurse, or pharmacist if you have questions about your medicines. Take medicines as directed. Do NOT stop taking
More informationCARDIAC IMAGING QUESTIONNAIRE
Date of test: / / Month day year Last name First name Middle initial Street address City State Zip code Home phone ( ) - Work phone ( ) - Cell Phone ( ) - Email: Age: Demographics: What is your ethnicity?
More informationNATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE 1 Guideline title SCOPE Myocardial infarction: secondary prevention in primary and secondary care for patients following a myocardial infarction 1.1
More informationHypertension is also an important risk factor in the development of chronic kidney disease and heart failure.
Hypertension Hypertension Hypertension is defined as either a sustained systolic blood pressure of greater than 140 mm Hg or a sustained diastolic blood pressure of greater than 90 mm Hg. Hypertension
More informationCHAPTER 2. Knowing YOUR MEDICATIONS. Image: istock.com/bakibg. Knowing Your Medications 23
CHAPTER 2 Knowing YOUR MEDICATIONS Knowing Your Medications 23 Image: istock.com/bakibg MEDICATION Prescription medications help your heart get better and protect you from more harm. People who take their
More informationHypertension diagnosis (see detail document) Diabetic. Target less than 130/80mmHg
Hypertension diagnosis (see detail document) Non-diabetic Diabetic Very elderly (older than 80 years) Target less than 140/90mmHg Target less than 130/80mmHg Consider SBP target less than 150mmHg Non-diabetic
More informationAntihypertensives. Antihypertensive Classes. RAAS Inhibitors. Renin-Angiotensin Cascade. Angiotensin Receptors. Approaches to Hypertension Treatment
Approaches to Hypertension Treatment Antihypertensives Inhibit Sympathetic impulses Inhibit contractility Inhibit heart rate Inhibit vasoconstriction Inhibit smooth muscle function Inhibit RAAS Inhibit
More informationCardiovascular Clinical Practice Guideline Pilot Implementation
Cardiovascular Clinical Practice Guideline Pilot Implementation Pharmacologic Management of Chronic Heart Failure Sept 15, 2004 Angela Allerman, PharmD, BCPS DoD Pharmacoeconomic Center Promoting high
More informationThe ADDITION Study: A study about screening for diabetes. Screening Case Report Form
ADDITION Study, Leicester Participant Identification Label: Date: / / The ADDITION Study: A study about screening for diabetes Screening Case Report Form You will need to have the following things done
More informationCardiac Drugs: Chapter 9 Worksheet Cardiac Agents. 1. drugs affect the rate of the heart and can either increase its rate or decrease its rate.
Complete the following. 1. drugs affect the rate of the heart and can either increase its rate or decrease its rate. 2. drugs affect the force of contraction and can be either positive or negative. 3.
More information7/7/ CHD/MI LVH and LV dysfunction Dysrrhythmias Stroke PVD Renal insufficiency and failure Retinopathy. Normal <120 Prehypertension
Prevalence of Hypertension Hypertension: Diagnosis and Management T. Villela, M.D. Program Director University of California, San Francisco-San Francisco General Hospital Family and Community Medicine
More informationSTANDARD treatment algorithm mmHg
STANDARD treatment algorithm 130-140mmHg (i) At BASELINE, If AVERAGE SBP 1 > 140mmHg If on no antihypertensive drugs: Start 1 drug: If >55 years old / Afro-Caribbean: Calcium channel blocker (CCB) 2 If
More informationYounger adults with a family history of premature artherosclerotic disease should have their cardiovascular risk factors measured.
Appendix 2A - Guidance on Management of Hypertension Measurement of blood pressure All adults from 40 years should have blood pressure measured as part of opportunistic cardiovascular risk assessment.
More informationWhat in the World is Functional Medicine?
What in the World is Functional Medicine? An Introduction to a Systems Based Approach of Chronic Disease Meneah R Haworth, FNP-C Disclosure v I am a student of the Institute for Functional Medicine. They
More informationSection 3, Lecture 2
59-291 Section 3, Lecture 2 Diuretics: -increase in Na + excretion (naturesis) Thiazide and Related diuretics -decreased PVR due to decreases muscle contraction -an economical and effective treatment -protect
More informationTherapeutic options for adult patients unable to take solid oral dosage forms (Adapted from UKMi Q&A for use in Northern Ireland) Sep 2015
Therapeutic options for adult patients unable to take solid oral dosage forms (Adapted from UKMi Q&A 294.3 for use in Northern Ireland) Sep 2015 BNF 1.3.5 Proton pump inhibitors Lansoprazole orodispersible
More informationChest Pain Acute Coronary Syndrome Version 4 4/10/17 This order set is designed to be used with an admission set or for a patient already admitted
Patient Name: Diagnosis: Allergies with reaction type: Chest Pain Acute Coronary Syndrome Version 4 4/10/17 This order set is designed to be used with an admission set or for a patient already admitted
More informationClinical Teach-Back Cards
Clinical Teach-Back Cards The Quality Innovation Network - Quality Improvement Organization (QIN-QIO) for Delaware, Louisiana, New Jersey, Pennsylvania and West Virginia The people at Quality Insights
More informationREGISTRATION CRITERIA : SPECIALIST INITIATION OF TREATMENT AND FOR ANY SIGNIFICANT INCREASES IN DOSAGES OR ADDITION OF MEDICATION.
CORONARY ARTERY DISEASE REGISTRATION CRITERIA : SPECIALIST INITIATION OF TREATMENT AND FOR ANY SIGNIFICANT INCREASES IN DOSAGES OR ADDITION OF MEDICATION. * REQUEST FOR ANGIO-TENSIN RECEPTOR BLOCKER WILL
More informationInventory of paediatric therapeutic needs
24 April 2013 EMA/PDCO/246339/2013 Human Medicines Development and Evaluation Cardiovascular therapeutic area Agreed by PDCO August 2012 Adopted by PDCO for release for consultation 15-17 August 2012 Start
More informationTowards a Greater Understanding of Cardiac Medications Foundational Cardiac Concepts That Must Be Understood:
Towards a Greater Understanding of Cardiac Medications Foundational Cardiac Concepts That Must Be Understood: Cardiac Output (CO) CO=SVxHR (stroke volume x heart rate) Cardiac output: The amount of blood
More informationLESSON ASSIGNMENT. After completing this lesson you will be able to:
LESSON ASSIGNMENT SUBCOURSE MD0806 LESSON 7 Therapeutics III. Antihypertensive Agents. LESSON ASSIGNMENT Paragraphs 7-1--7-12. LESSON OBJECTIVES After completing this lesson you will be able to: 7-1. From
More informationHeart Failure (HF) Treatment
Heart Failure (HF) Treatment Heart Failure (HF) Complex, progressive disorder. The heart is unable to pump sufficient blood to meet the needs of the body. Its cardinal symptoms are dyspnea, fatigue, and
More informationEliquis and plavix combination therapy
Eliquis and plavix combination therapy ELIQUIS Dosing for Patients With NVAF. patients treated with aspirin or the combination of bleeding or completion of a course of therapy,. 9-11-2011 Thrombosis is
More information1/4/18. Heart Failure Guideline Review and Update. Disclosure. Pharmacist Objectives. Pharmacy Technician Objectives. What is Heart Failure?
Disclosure Heart Failure Guideline Review and Update I have had no financial relationship over the past 12 months with any commercial sponsor with a vested interest in this presentation. Natalie Beiter,
More informationHypertensionTreatment Guidelines. Michaelene Urban APRN, MSN, ACNS-BC, ANP-BC
HypertensionTreatment Guidelines Michaelene Urban APRN, MSN, ACNS-BC, ANP-BC Objectives: Review the definition of the different stages of HTN. Review the current guidelines for treatment of HTN. Provided
More informationAdapted d from Federation of Health Regulatory Colleges of Ontario Template Last Updated September 18, 2017
Insert Logo or Org Name Here Primary Care Medical Directive for Hypertension Management Adapted d from Federation of Health Regulatory Colleges of Ontario Template Last Updated September 18, 2017 Title:
More informationDose. Route. Units. Given. Special situations. Dose. Route. Units. Given. Special situations
Chapter 3 Cardiology Georgia Woodfield ASPIRIN FONDAPARINUX 300 once only in acute MI 75 in primary/ secondary prevention of thrombus formation and thromboembolic disease or PR; can also be given via nasogastric
More informationReport generated from BNF - NNUH Formulary provided by FormularyComplete (www.pharmpress.com). Accessed
Report generated from BNF - NNUH Formulary provided by FormularyComplete (www.pharmpress.com). Accessed 24 11 2017 This is a live document. Changes may have been made to the formulary since this report
More informationFactors Involved in Poor Control of Risk Factors
Factors Involved in Poor Control of Risk Factors Patient compliance Clinical inertia Health Care System structure 14781 M Limitations of Formal Studies Selection of patients Recruitment and follow-up alter
More informationUpdates in Therapeutics: 2013 Pharmacotherapy Preparatory Review and Recertification Course
AMERICAN COLLEGE OF CLINICAL PHARMACY Updates in Therapeutics: 2013 Pharmacotherapy Preparatory Review and Recertification Course POSTTEST ANSWERS SESSION 8 Cardiology I 1. Answer B: NTG intravenously
More informationHypertension Management - Summary
Who should have blood pressure assessed? Hypertension Management - Summary All patients over the age of 40 years, every 1-3 years in order to determine their cardiovascular risk (ie. Framingham Risk Score)
More informationCOPYRIGHTED MATERIAL. Index. Ó 2009 John Wiley & Sons, Ltd
Index Figures and Tables are indicated by italic page numbers, Boxes by bold numbers. Abbreviations: ACS ¼ acute coronary syndrome; ECG ¼ electrocardiography; MI ¼ myocardial infarction; PCI ¼ percutaneous
More information12.5mg, 25mg, 50mg. 25mg, 50mg. 250mg, 500mg, 250mg/5ml. 2.5mg, 5mg, 10mg. 5mg, 10mg, 20mg, 100mg. 25mg
MEDICATION COVERAGE POLICY PHARMACY AND THERAPEUTICS ADVISORY COMMITTEE POLICY: Blood Pressure P&T DATE: 9/11/2018 THERAPEUTIC CLASS: Cardiovascular Disorders REVIEW HISTORY: 5/17, 9/15, 2/13, 2/08, LOB
More informationCardiovascular System
CHAPTER 2 CARDIOVASCULAR SYSTEM 2.1 Acute stroke NICE CG68 - Diagnosis and initial management of acute stroke and transient ischaemic attack (TIA), July 2008 and NICE TA 210 - Vascular disease clopidogrel
More informationAntiplatelets and Anticoagulants. Helen Leung, PharmD PGY1 Pharmacy Resident Memorial Hermann-Texas Medical Center
Antiplatelets and Anticoagulants Helen Leung, PharmD PGY1 Pharmacy Resident Memorial Hermann-Texas Medical Center Mechanism 2 http://www.medicinehack.com/2011/07/virchows-triad.html Mechanism 3 http://drtedwilliams.net/kb/index.php?pagename=coagulation%20cascade
More informationANTIHYPERTENSIVES. Assoc. Prof. Bilgen Başgut
ANTIHYPERTENSIVES Assoc. Prof. Bilgen Başgut Hypertension Hypertension is a condition in which the blood pressure is persistently higher than normal Hypertension > 140 mmhg > 90 mmhg Systolic Blood Pressure
More informationDRUG CLASSES BETA-ADRENOCEPTOR ANTAGONISTS (BETA-BLOCKERS)
DRUG CLASSES BETA-ADRENOCEPTOR ANTAGONISTS (BETA-BLOCKERS) Beta-blockers have been widely used in the management of angina, certain tachyarrhythmias and heart failure, as well as in hypertension. Examples
More informationCardiology. Self Learning Package. Module 5: Pharmacology: Treatment of Acute Coronary. Prevention
Cardiology Self Learning Package Module 5: Pharmacology: Treatment of Acute Coronary Syndromes, Module 5: Pharmacology: Hyperlipidaemia, Treatment of Acute Coronary Hypertension, Symdrome, Hyperlipidaemia,
More informationREGISTRATION CRITERIA : SPECIALIST INITIATION OF TREATMENT AND FOR ANY SIGNIFICANT INCREASES IN DOSAGES OR ADDITION OF MEDICATION.
CARDIOMYOPATHY REGISTRATION CRITERIA : SPECIALIST INITIATION OF TREATMENT AND FOR ANY SIGNIFICANT INCREASES IN DOSAGES OR ADDITION OF MEDICATION. * REQUEST FOR ANGIO-TENSIN RECEPTOR BLOCKER WILL REQUIRE
More informationHeart failure Management of symptoms and treatment
2 Heart failure Management of symptoms and treatment 1 Managing heart failure Contents The Heartbeat Trust is Ireland s national heart failure charity (CHY 5938). It supports specialist clinical and research
More informationManaging IHD and acute Myocardial Infarction
Managing IHD and acute Myocardial Infarction In Ireland- 1 out of every 10 deaths ( 22% of all premature deaths) in 2006 were due to CVD 30,000 15,000 0 1998 1999 2000 2001 2002 2003 2004 2005 2006 Source
More informationMedical Management of Acute Coronary Syndrome: The roles of a noncardiologist. Norbert Lingling D. Uy, MD Professor of Medicine UERMMMCI
Medical Management of Acute Coronary Syndrome: The roles of a noncardiologist physician Norbert Lingling D. Uy, MD Professor of Medicine UERMMMCI Outcome objectives of the discussion: At the end of the
More informationAdditional Standard Generics HSA Preventive Drug List Effective January 1, 2019
Additional Standard Generics HSA Preventive Drug List Effective January 1, 2019 Employers can elect to include an additional generic HSA Preventive Drug coverage feature with your prescription benefit
More informationChapter 23. Media Directory. Cardiovascular Disease (CVD) Hypertension: Classified into Three Categories
Chapter 23 Drugs for Hypertension Slide 37 Slide 41 Media Directory Nifedipine Animation Doxazosin Animation Upper Saddle River, New Jersey 07458 All rights reserved. Cardiovascular Disease (CVD) Includes
More information8/20/2018. Objectives. What is hypertension? cont. What is hypertension? Epidemiology cont. Epidemiology
Objectives Hypertension (high blood pressure): Clinical Pearls for the Pharmacy Technician Tanya Schmidt PharmD, RPh Director of Central Operations at Thrifty White Pharmacy North Dakota Board of Pharmacy
More informationAntihypertensives. Diagnostic category
Measurement of blood pressure At first assessment, take both arms then choose the one with the higher reading. Beware of orthostatic hypotension. Measure BP in sitting position, and repeat after patient
More informationUniversity of Al Qadisiyah College of Pharmacy Dr. Bassim I Mohammad, MBChB, MSc, Ph.D
University of Al Qadisiyah College of Pharmacy Dr. Bassim I Mohammad, MBChB, MSc, Ph.D Cardiovascular Pharmacology 1. Antihypertensives 2. Antianginal 3. Drugs for HF 4. Antiarrythemics 5. Drugs for Hyperlipoproteniemia
More informationVolume 6; Number 1 January 2012 NICE CLINICAL GUIDELINE 127: HYPERTENSION CLINICAL MANAGEMENT OF PRIMARY HYPERTENSION IN ADULTS (AUGUST 2011)
Volume 6; Number 1 January 2012 NICE CLINICAL GUIDELINE 127: HYPERTENSION CLINICAL MANAGEMENT OF PRIMARY HYPERTENSION IN ADULTS (AUGUST 2011) What s new in hypertension? NICE has issued an updated Clinical
More informationAnticoagulation Management Around Endoscopy: GI Perspective. Nathan Landesman, DO FACOI Flint Gastroenterology Associates October 11, 2017
Anticoagulation Management Around Endoscopy: GI Perspective Nathan Landesman, DO FACOI Flint Gastroenterology Associates October 11, 2017 EDUCATIONAL OBJECTIVES Understand risks of holding anticoagulation
More informationChapter 10. Learning Objectives. Learning Objectives 9/11/2012. Congestive Heart Failure
Chapter 10 Congestive Heart Failure Learning Objectives Explain concept of polypharmacy in treatment of congestive heart failure Explain function of diuretics Learning Objectives Discuss drugs used for
More information11/4/2017. but cocaine toxicity is complex: Pro thrombotic effects Progressive atherosclerosis Ventricular remodeling
2 Learning Objectives ATRIUM Fall Patient Safety Webinar Cardiology Mythbusters: Vol 1 Brent N. Reed, PharmD, BCPS AQ Cardiology Associate Professor, University of Maryland School of Pharmacy This presentation
More informationsympatholytics sympatholytics sympatholytics
sympatholytics sympatholytics sympatholytics CNS-ACTING SYMPATHOPLEGICS Sympathetic brain signals Doesn t affect baroreceptor reflex (no orthostatic hypotension) Methyldopa α-methylne crosses BBB (+) α-adrenoreceptors
More informationCodes for a Medicare claims-based model to predict LVEF class- User Guide
Description and citation: This guide accompanies our manuscript [Desai RJ, Lin KJ, Patorno E, et al. Development and Preliminary Validation of a Medicare Claims Based Model to Predict Left Ventricular
More informationPrescribing Formulary. 6 th Edition October 2009
Prescribing Formulary 6 th Edition October 2009 Somerset Primary Care Trust - Primary Care Formulary 6th Edition October 2009 Introduction This formulary has been developed and reviewed by the Somerset
More informationReview Protocol Patient information
Review Protocol Patient information What are information needs of patients with stable angina regarding their condition and its management? Adults with a diagnosis of stable angina including people with
More informationProposal Relating to the Funding of Certain Pharmaceuticals in DHB Hospitals
3 August 2012 Proposal Relating to the Funding of Certain Pharmaceuticals in DHB Hospitals PHARMAC is seeking feedback on a proposal relating to the establishment of a nationallyconsistent list of pharmaceuticals
More informationVolume 5; Number 17 October 2011
Volume 5; Number 17 October 2011 What s new this month? Dabigatran etexilate (Pradaxa) is evaluated for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation
More information